These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18003990)

  • 1. Feasibility and efficacy of percutaneous transcatheter intraarterial chemotherapy with paclitaxel in albumin nanoparticles for advanced squamous-cell carcinoma of the oral cavity, oropharynx, and hypopharynx.
    Damascelli B; Patelli G; Tichá V; Di Tolla G; Frigerio LF; Garbagnati F; Lanocita R; Marchianò A; Spreafico C; Mattavelli F; Bruno A; Zunino F
    J Vasc Interv Radiol; 2007 Nov; 18(11):1395-403. PubMed ID: 18003990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findings.
    Damascelli B; Patelli GL; Lanocita R; Di Tolla G; Frigerio LF; Marchianò A; Garbagnati F; Spreafico C; Tichà V; Gladin CR; Palazzi M; Crippa F; Oldini C; Calò S; Bonaccorsi A; Mattavelli F; Costa L; Mariani L; Cantù G
    AJR Am J Roentgenol; 2003 Jul; 181(1):253-60. PubMed ID: 12818869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to intraarterial induction chemotherapy: a prognostic parameter in oral and oropharyngeal cancer.
    Kovács AF
    Head Neck; 2006 Aug; 28(8):678-88. PubMed ID: 16721739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical trial of chemotherapy by superselective intra-arterial infusion of nedaplatin combined with radiotherapy for advanced oral cancer].
    Yamshita Y; Shikimori M; Goto M
    Gan To Kagaku Ryoho; 2005 Sep; 32(9):1267-71. PubMed ID: 16184922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy protocol for stage III or IV carcinoma of the oral cavity, oropharynx and hypopharynx.
    Schuller DE; King GW; Smith RE; Wilson HE; James AD; Batley F
    Laryngoscope; 1980 Aug; 90(8 Pt 1):1263-72. PubMed ID: 7401827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience.
    Schuller DE; Ozer E; Agrawal A; Grecula JC; Rhoades CA; Young DC
    Arch Otolaryngol Head Neck Surg; 2007 Apr; 133(4):320-6. PubMed ID: 17438244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer.
    Ibrahim NK; Samuels B; Page R; Doval D; Patel KM; Rao SC; Nair MK; Bhar P; Desai N; Hortobagyi GN
    J Clin Oncol; 2005 Sep; 23(25):6019-26. PubMed ID: 16135470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
    Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
    J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of paclitaxel and nedaplatin as first-line chemotherapy in patients with advanced esophageal cancer.
    Cao W; Xu C; Lou G; Jiang J; Zhao S; Geng M; Xi W; Li H; Jin Y
    Jpn J Clin Oncol; 2009 Sep; 39(9):582-7. PubMed ID: 19509000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of base of tongue cancer with paclitaxel, ifosfamide, and cisplatinum induction chemotherapy followed by chemoradiotherapy.
    Hancock SB; Krempl GA; Canfield V; Bogardus C; Kojouri K; Kaneaster SK; Medina JE
    Laryngoscope; 2008 Aug; 118(8):1357-61. PubMed ID: 18528311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II clinical trial of parenteral hydroxyurea and hyper-fractionated, accelerated external beam radiation therapy in patients with advanced squamous cell carcinoma of the head and neck: toxicity and efficacy with continuous ribonucleoside reductase inhibition.
    Beitler JJ; Smith RV; Owen RP; Silver CE; Mazumdar M; Wadler S
    Head Neck; 2007 Jan; 29(1):18-25. PubMed ID: 16983691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.
    Rossi D; Dennetta D; Ugolini M; Alessandroni P; Catalano V; Fedeli SL; Giordani P; Casadei V; Baldelli AM; Graziano F; Catalano G
    Clin Lung Cancer; 2008 Sep; 9(5):280-4. PubMed ID: 18824450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of intra-arterial infusion chemotherapy for head and neck cancers using coaxial catheter technique: initial experience.
    Tsurumaru D; Kuroiwa T; Yabuuchi H; Hirata H; Higaki Y; Tomita K
    Cardiovasc Intervent Radiol; 2007; 30(2):207-11. PubMed ID: 17216381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of weekly paclitaxel and epirubicin in recurrent or refractory squamous cell carcinoma of the head and neck.
    Wang TF; Chu SC; Kao RH; Yao CY; Li CC
    Jpn J Clin Oncol; 2008 Jul; 38(7):459-63. PubMed ID: 18586668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The remission of extensive cancers of the mouth and oropharynx with intra-arterial polychemotherapy with vincristine, methotrexate, bleomycin, cisplatin (VMBP)].
    Mika H
    Laryngol Rhinol Otol (Stuttg); 1982 Sep; 61(9):520-3. PubMed ID: 6183545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superselective intra-arterial infusion chemotherapy for stage III/IV squamous cell carcinomas of the oral cavity: midterm results.
    Ikushima I; Korogi Y; Ishii A; Hirai T; Yamura M; Nishimura R; Baba Y; Yamashita Y; Shinohara M
    Eur J Radiol; 2008 Apr; 66(1):7-12. PubMed ID: 17604932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-arterial chemoradiation for T3-4 oral cavity cancer: treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma.
    Doweck I; Robbins KT; Samant S; Vieira F
    World J Surg Oncol; 2008 Jan; 6():2. PubMed ID: 18194553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of a multimodal intensification regimen for previously untreated advanced resectable squamous cell cancer of the oral cavity, oropharynx, or hypopharynx.
    Ozer E; Grecula JC; Agrawal A; Rhoades CA; Young DC; Schuller DE
    Laryngoscope; 2006 Apr; 116(4):607-12. PubMed ID: 16585867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.